Penserra Capital Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.3M Buy
1,194,853
+45,585
+4% +$898K 0.2% 131
2026
Q1
$20.4M Sell
1,149,268
-171,877
-13% -$3.25M 0.24% 119
2025
Q4
$25M Buy
1,321,145
+122,290
+10% +$2.31M 0.3% 107
2025
Q3
$22.1M Buy
1,198,855
+159,618
+15% +$2.61M 0.26% 106
2025
Q2
$16.1M Buy
1,039,237
+30,711
+3% +$476K 0.22% 148
2025
Q1
$16.4M Buy
1,008,526
+78,771
+8% +$1.35M 0.29% 98
2024
Q4
$14.9M Buy
929,755
+62,626
+7% +$1.11M 0.27% 92
2024
Q3
$16.1M Buy
+867,129
New +$16.2M 0.35% 64

Other funds holding HQH

Penserra Capital Management's HQH Position: Q2 2026 in Review

Penserra Capital Management increased its abrdn Healthcare Investors (HQH) stake by 4% in Q2 2026, buying an estimated $898K and bringing the position to 1,194,853 shares worth $26.3M. The position accounts for 0.2% of the portfolio, ranked #131.

Penserra Capital Management first reported a position in HQH in Q3 2024 and has held it in 8 quarters since. 126 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • Penserra Capital Management held 1,194,853 shares of abrdn Healthcare Investors worth $26.3M as of Q2 2026.
  • Penserra Capital Management bought 45,585 abrdn Healthcare Investors shares in Q2 2026, an estimated $898K.
  • abrdn Healthcare Investors made up 0.2% of Penserra Capital Management's portfolio in Q2 2026, its #131 holding.
  • Penserra Capital Management first reported a position in abrdn Healthcare Investors in Q3 2024 and has held it in 8 quarters since.
  • 126 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.